SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4q38'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HK3_A_T44A3001_1 (SERUM ALBUMIN)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	5 / 11	TRP A 163 PRO A 93 LEU A 173 HIS A 196 ALA A 184	TEC A 404 (-4.6A) None None TEC A 404 (-4.1A) None	1.46A	1hk3A-4q38A: undetectable	1hk3A-4q38A: 19.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NW5_A_SAMA401_1 (MODIFICATION METHYLASE RSRI)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	3 / 3	ASP A 275 HIS A 306 ASP A 240	None	0.63A	1nw5A-4q38A: undetectable	1nw5A-4q38A: 23.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QZR_B_CDXB901_1 (DNA TOPOISOMERASE II)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	4 / 7	ASN A 286 TYR A 285 LEU A 293 GLN A 288	None	1.00A	1qzrA-4q38A: 0.0	1qzrA-4q38A: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QZR_B_CDXB901_2 (DNA TOPOISOMERASE II)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	4 / 7	ASN A 286 TYR A 285 LEU A 293 GLN A 288	None	0.90A	1qzrB-4q38A: undetectable	1qzrB-4q38A: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1TW4_A_CHDA130_0 (FATTY ACID-BINDING PROTEIN)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	5 / 12	LEU A 23 LEU A 20 ALA A 81 ILE A 82 THR A 166	None	0.96A	1tw4A-4q38A: undetectable	1tw4A-4q38A: 15.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZP4_C_C2FC997_0 (5,10-METHYLENETETRAH YDROFOLATE REDUCTASE)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	5 / 10	ASP A 275 GLN A 242 SER A 251 TYR A 246 LEU A 299	None None COA A 403 (-2.5A) None COA A 403 (-3.9A)	1.43A	1zp4C-4q38A: 0.0	1zp4C-4q38A: 21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZU_A_MTLA870_0 (NITRIC-OXIDE SYNTHASE, BRAIN)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	4 / 8	SER A 212 ARG A 215 GLN A 180 PHE A 181	None	1.05A	1zzuA-4q38A: undetectable	1zzuA-4q38A: 22.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3C_A_PNXA1435_1 (CHITINASE)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	4 / 6	TRP A 260 GLY A 194 PHE A 181 SER A 182	TEC A 404 (-4.0A) None None None	1.19A	2a3cA-4q38A: undetectable	2a3cA-4q38A: 21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3C_B_PNXB2434_1 (CHITINASE)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	4 / 6	TRP A 260 GLY A 194 PHE A 181 SER A 182	TEC A 404 (-4.0A) None None None	1.22A	2a3cB-4q38A: undetectable	2a3cB-4q38A: 21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2BXE_A_1FLA2003_1 (SERUM ALBUMIN)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	5 / 9	LEU A 99 PHE A 110 LEU A 12 LEU A 20 ALA A 70	None	1.20A	2bxeA-4q38A: undetectable	2bxeA-4q38A: 19.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2BXG_A_IBPA2002_1 (SERUM ALBUMIN)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	4 / 8	ARG A 151 ALA A 55 GLU A 57 VAL A 112	None	0.79A	2bxgA-4q38A: undetectable	2bxgA-4q38A: 19.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2BXP_A_P1ZA3001_1 (SERUM ALBUMIN)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	5 / 12	LEU A 99 PHE A 110 LEU A 12 LEU A 20 ALA A 70	None	1.21A	2bxpA-4q38A: undetectable	2bxpA-4q38A: 19.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2H42_C_VIAC903_2 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	3 / 3	ASN A 286 ILE A 149 MET A 161	None None TEC A 404 (-4.3A)	0.62A	2h42C-4q38A: undetectable	2h42C-4q38A: 19.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HA4_A_ACTA544_0 (ACETYLCHOLINESTERASE)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	4 / 8	GLY A 104 GLY A 103 ALA A 106 ALA A 107	None	0.59A	2ha4A-4q38A: undetectable	2ha4A-4q38A: 21.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HA4_B_ACTB601_0 (ACETYLCHOLINESTERASE)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	4 / 7	GLY A 104 GLY A 103 ALA A 106 ALA A 107	None	0.60A	2ha4B-4q38A: undetectable	2ha4B-4q38A: 21.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ADS_A_IMNA2_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	5 / 12	HIS A 79 LEU A 35 LEU A 45 PHE A 115 LEU A 169	None	1.47A	3adsA-4q38A: undetectable	3adsA-4q38A: 21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3L2V_A_RLTA397_1 (INTEGRASE)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	4 / 7	ASP A 291 PRO A 289 GLN A 288 GLU A 292	None	1.17A	3l2vA-4q38A: undetectable	3l2vA-4q38A: 20.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LN1_A_CELA682_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	5 / 12	TYR A 209 LEU A 204 ALA A 216 GLY A 234 SER A 236	None COA A 403 (-4.6A) None TEC A 404 ( 3.9A) COA A 403 (-3.1A)	0.98A	3ln1A-4q38A: undetectable	3ln1A-4q38A: 19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LN1_A_CELA682_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	5 / 12	VAL A 197 TYR A 209 LEU A 204 ALA A 216 GLY A 234	TEC A 404 ( 4.2A) None COA A 403 (-4.6A) None TEC A 404 ( 3.9A)	0.89A	3ln1A-4q38A: undetectable	3ln1A-4q38A: 19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LN1_B_CELB682_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	5 / 12	TYR A 209 LEU A 204 ALA A 216 GLY A 234 SER A 236	None COA A 403 (-4.6A) None TEC A 404 ( 3.9A) COA A 403 (-3.1A)	1.00A	3ln1B-4q38A: undetectable	3ln1B-4q38A: 19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LN1_B_CELB682_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	5 / 12	VAL A 197 TYR A 209 LEU A 204 ALA A 216 GLY A 234	TEC A 404 ( 4.2A) None COA A 403 (-4.6A) None TEC A 404 ( 3.9A)	0.91A	3ln1B-4q38A: undetectable	3ln1B-4q38A: 19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LN1_C_CELC682_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	5 / 12	TYR A 209 LEU A 204 ALA A 216 GLY A 234 SER A 236	None COA A 403 (-4.6A) None TEC A 404 ( 3.9A) COA A 403 (-3.1A)	0.98A	3ln1C-4q38A: undetectable	3ln1C-4q38A: 19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LN1_C_CELC682_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	5 / 12	VAL A 197 TYR A 209 LEU A 204 ALA A 216 GLY A 234	TEC A 404 ( 4.2A) None COA A 403 (-4.6A) None TEC A 404 ( 3.9A)	0.89A	3ln1C-4q38A: undetectable	3ln1C-4q38A: 19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LN1_D_CELD682_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	5 / 12	VAL A 197 TYR A 209 LEU A 204 ALA A 216 GLY A 234	TEC A 404 ( 4.2A) None COA A 403 (-4.6A) None TEC A 404 ( 3.9A)	0.90A	3ln1D-4q38A: undetectable	3ln1D-4q38A: 19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N62_B_MTLB870_0 (NITRIC OXIDE SYNTHASE)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	4 / 8	SER A 212 ARG A 215 GLN A 180 PHE A 181	None	1.17A	3n62B-4q38A: undetectable	3n62B-4q38A: 22.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OWX_A_XRAA233_1 (RIBOSYLDIHYDRONICOTI NAMIDE DEHYDROGENASE [QUINONE])	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	5 / 9	GLY A 157 GLY A 158 ASN A 160 GLU A 57 ILE A 58	None	1.36A	3owxA-4q38A: undetectable	3owxA-4q38A: 21.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4B3Q_A_NVPA999_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	4 / 7	LEU A 45 VAL A 119 TYR A 113 LEU A 143	None	0.90A	4b3qA-4q38A: undetectable	4b3qA-4q38A: 20.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EJJ_A_NCTA501_1 (CYTOCHROME P450 2A6)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	4 / 7	PHE A 224 GLY A 171 ILE A 131 PHE A 219	None	0.81A	4ejjA-4q38A: undetectable	4ejjA-4q38A: 20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FGL_D_CLQD303_1 (RIBOSYLDIHYDRONICOTI NAMIDE DEHYDROGENASE [QUINONE])	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	4 / 6	GLY A 157 GLY A 158 GLU A 57 ILE A 58	None	0.89A	4fglD-4q38A: undetectable	4fglD-4q38A: 21.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MFL_B_GCSB502_1 (PUTATIVE UNCHARACTERIZED PROTEIN TCP24 TEICOPLANIN PSEUDOAGLYCONE)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	5 / 6	GLN A 142 MET A 161 TRP A 163 TRP A 164 PHE A 281	TEC A 404 ( 4.0A) TEC A 404 (-4.3A) TEC A 404 (-4.6A) TEC A 404 (-3.7A) COA A 403 (-3.4A)	0.66A	4mflA-4q38A: 51.3	4mflA-4q38A: 97.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MFP_B_GCSB503_1 (PUTATIVE UNCHARACTERIZED PROTEIN TCP24 TEICOPLANIN PSEUDOAGLYCONE)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	5 / 5	GLN A 142 MET A 161 TRP A 163 TRP A 164 PHE A 281	TEC A 404 ( 4.0A) TEC A 404 (-4.3A) TEC A 404 (-4.6A) TEC A 404 (-3.7A) COA A 403 (-3.4A)	0.34A	4mfpA-4q38A: 50.5	4mfpA-4q38A: 97.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MFQ_B_GCSB503_1 (PUTATIVE UNCHARACTERIZED PROTEIN TCP24 TEICOPLANIN PSEUDOAGLYCONE)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	5 / 6	GLN A 142 MET A 161 TRP A 163 TRP A 164 PHE A 281	TEC A 404 ( 4.0A) TEC A 404 (-4.3A) TEC A 404 (-4.6A) TEC A 404 (-3.7A) COA A 403 (-3.4A)	0.73A	4mfqA-4q38A: 50.8	4mfqA-4q38A: 97.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O0W_A_ADNA501_1 (AURORA KINASE A)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	5 / 6	LEU A 10 GLY A 11 ALA A 70 THR A 16 LEU A 20	None	0.91A	4o0wA-4q38A: undetectable	4o0wA-4q38A: 22.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4Q36_A_GCSA404_1 (PUTATIVE UNCHARACTERIZED PROTEIN TCP24)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	5 / 5	MET A 161 TRP A 163 TRP A 164 HIS A 196 PHE A 281	TEC A 404 (-4.3A) TEC A 404 (-4.6A) TEC A 404 (-3.7A) TEC A 404 (-4.1A) COA A 403 (-3.4A)	0.13A	4q36A-4q38A: 50.9	4q36A-4q38A: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R82_A_ACTA205_0 (OXIDOREDUCTASE)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	4 / 5	GLY A 87 ARG A 129 GLU A 226 PHE A 224	None	1.22A	4r82A-4q38A: undetectable 4r82B-4q38A: undetectable	4r82A-4q38A: 21.04 4r82B-4q38A: 21.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	5 / 7	GLY A 234 SER A 235 GLY A 318 VAL A 320 LEU A 262	TEC A 404 ( 3.9A) None None None None	1.28A	5izjB-4q38A: undetectable	5izjB-4q38A: 20.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5JW1_A_CELA602_1 (PROSTAGLANDIN G/H SYNTHASE 2)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	6 / 12	VAL A 197 TYR A 209 LEU A 204 ALA A 216 GLY A 234 SER A 236	TEC A 404 ( 4.2A) None COA A 403 (-4.6A) None TEC A 404 ( 3.9A) COA A 403 (-3.1A)	1.22A	5jw1A-4q38A: undetectable	5jw1A-4q38A: 21.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6G2P_A_TRPA502_0 (FLAVIN-DEPENDENT L-TRYPTOPHAN OXIDASE VIOA)	4q38	PUTATIVE UNCHARACTERIZED PROTEIN TCP24 (Actinoplanes teichomyceticus)	4 / 7	TYR A 113 LEU A 143 TYR A 109 VAL A 50	None	1.33A	6g2pA-4q38A: undetectable	6g2pA-4q38A: 22.12

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1HK3_A_T44A3001_1","SERUM ALBUMIN","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",5,"TRP A 163;PRO A  93;LEU A 173;HIS A 196;ALA A 184","TEC A 404 (-4.6A);None;None;TEC A 404 (-4.1A);None","1.46A","1hk3A-4q38A:undetectable","1hk3A-4q38A:19.20"],["1NW5_A_SAMA401_1","MODIFICATION METHYLASE RSRI","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",3,"ASP A 275;HIS A 306;ASP A 240","None","0.63A","1nw5A-4q38A:undetectable","1nw5A-4q38A:23.34"],["1QZR_B_CDXB901_1","DNA TOPOISOMERASE II;DNA TOPOISOMERASE II","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",4,"ASN A 286;TYR A 285;LEU A 293;GLN A 288","None","1.00A","1qzrA-4q38A:0.0","1qzrA-4q38A:19.54"],["1QZR_B_CDXB901_2","DNA TOPOISOMERASE II","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",4,"ASN A 286;TYR A 285;LEU A 293;GLN A 288","None","0.90A","1qzrB-4q38A:undetectable","1qzrB-4q38A:19.54"],["1TW4_A_CHDA130_0","FATTY ACID-BINDING PROTEIN","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",5,"LEU A  23;LEU A  20;ALA A  81;ILE A  82;THR A 166","None","0.96A","1tw4A-4q38A:undetectable","1tw4A-4q38A:15.54"],["1ZP4_C_C2FC997_0","5,10-METHYLENETETRAHYDROFOLATE REDUCTASE","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",5,"ASP A 275;GLN A 242;SER A 251;TYR A 246;LEU A 299","None;None;COA A 403 (-2.5A);None;COA A 403 (-3.9A)","1.43A","1zp4C-4q38A:0.0","1zp4C-4q38A:21.14"],["1ZZU_A_MTLA870_0","NITRIC-OXIDE SYNTHASE, BRAIN","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",4,"SER A 212;ARG A 215;GLN A 180;PHE A 181","None","1.05A","1zzuA-4q38A:undetectable","1zzuA-4q38A:22.27"],["2A3C_A_PNXA1435_1","CHITINASE","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",4,"TRP A 260;GLY A 194;PHE A 181;SER A 182","TEC A 404 (-4.0A);None;None;None","1.19A","2a3cA-4q38A:undetectable","2a3cA-4q38A:21.14"],["2A3C_B_PNXB2434_1","CHITINASE","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",4,"TRP A 260;GLY A 194;PHE A 181;SER A 182","TEC A 404 (-4.0A);None;None;None","1.22A","2a3cB-4q38A:undetectable","2a3cB-4q38A:21.14"],["2BXE_A_1FLA2003_1","SERUM ALBUMIN","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",5,"LEU A  99;PHE A 110;LEU A  12;LEU A  20;ALA A  70","None","1.20A","2bxeA-4q38A:undetectable","2bxeA-4q38A:19.03"],["2BXG_A_IBPA2002_1","SERUM ALBUMIN","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",4,"ARG A 151;ALA A  55;GLU A  57;VAL A 112","None","0.79A","2bxgA-4q38A:undetectable","2bxgA-4q38A:19.03"],["2BXP_A_P1ZA3001_1","SERUM ALBUMIN","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",5,"LEU A  99;PHE A 110;LEU A  12;LEU A  20;ALA A  70","None","1.21A","2bxpA-4q38A:undetectable","2bxpA-4q38A:19.03"],["2H42_C_VIAC903_2","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",3,"ASN A 286;ILE A 149;MET A 161","None;None;TEC A 404 (-4.3A)","0.62A","2h42C-4q38A:undetectable","2h42C-4q38A:19.89"],["2HA4_A_ACTA544_0","ACETYLCHOLINESTERASE","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",4,"GLY A 104;GLY A 103;ALA A 106;ALA A 107","None","0.59A","2ha4A-4q38A:undetectable","2ha4A-4q38A:21.06"],["2HA4_B_ACTB601_0","ACETYLCHOLINESTERASE","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",4,"GLY A 104;GLY A 103;ALA A 106;ALA A 107","None","0.60A","2ha4B-4q38A:undetectable","2ha4B-4q38A:21.06"],["3ADS_A_IMNA2_1","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",5,"HIS A  79;LEU A  35;LEU A  45;PHE A 115;LEU A 169","None","1.47A","3adsA-4q38A:undetectable","3adsA-4q38A:21.14"],["3L2V_A_RLTA397_1","INTEGRASE","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",4,"ASP A 291;PRO A 289;GLN A 288;GLU A 292","None","1.17A","3l2vA-4q38A:undetectable","3l2vA-4q38A:20.48"],["3LN1_A_CELA682_1","PROSTAGLANDIN G\/H SYNTHASE 2","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",5,"TYR A 209;LEU A 204;ALA A 216;GLY A 234;SER A 236","None;COA A 403 (-4.6A);None;TEC A 404 ( 3.9A);COA A 403 (-3.1A)","0.98A","3ln1A-4q38A:undetectable","3ln1A-4q38A:19.76"],["3LN1_A_CELA682_1","PROSTAGLANDIN G\/H SYNTHASE 2","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",5,"VAL A 197;TYR A 209;LEU A 204;ALA A 216;GLY A 234","TEC A 404 ( 4.2A);None;COA A 403 (-4.6A);None;TEC A 404 ( 3.9A)","0.89A","3ln1A-4q38A:undetectable","3ln1A-4q38A:19.76"],["3LN1_B_CELB682_1","PROSTAGLANDIN G\/H SYNTHASE 2","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",5,"TYR A 209;LEU A 204;ALA A 216;GLY A 234;SER A 236","None;COA A 403 (-4.6A);None;TEC A 404 ( 3.9A);COA A 403 (-3.1A)","1.00A","3ln1B-4q38A:undetectable","3ln1B-4q38A:19.76"],["3LN1_B_CELB682_1","PROSTAGLANDIN G\/H SYNTHASE 2","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",5,"VAL A 197;TYR A 209;LEU A 204;ALA A 216;GLY A 234","TEC A 404 ( 4.2A);None;COA A 403 (-4.6A);None;TEC A 404 ( 3.9A)","0.91A","3ln1B-4q38A:undetectable","3ln1B-4q38A:19.76"],["3LN1_C_CELC682_1","PROSTAGLANDIN G\/H SYNTHASE 2","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",5,"TYR A 209;LEU A 204;ALA A 216;GLY A 234;SER A 236","None;COA A 403 (-4.6A);None;TEC A 404 ( 3.9A);COA A 403 (-3.1A)","0.98A","3ln1C-4q38A:undetectable","3ln1C-4q38A:19.76"],["3LN1_C_CELC682_1","PROSTAGLANDIN G\/H SYNTHASE 2","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",5,"VAL A 197;TYR A 209;LEU A 204;ALA A 216;GLY A 234","TEC A 404 ( 4.2A);None;COA A 403 (-4.6A);None;TEC A 404 ( 3.9A)","0.89A","3ln1C-4q38A:undetectable","3ln1C-4q38A:19.76"],["3LN1_D_CELD682_1","PROSTAGLANDIN G\/H SYNTHASE 2","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",5,"VAL A 197;TYR A 209;LEU A 204;ALA A 216;GLY A 234","TEC A 404 ( 4.2A);None;COA A 403 (-4.6A);None;TEC A 404 ( 3.9A)","0.90A","3ln1D-4q38A:undetectable","3ln1D-4q38A:19.76"],["3N62_B_MTLB870_0","NITRIC OXIDE SYNTHASE","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",4,"SER A 212;ARG A 215;GLN A 180;PHE A 181","None","1.17A","3n62B-4q38A:undetectable","3n62B-4q38A:22.27"],["3OWX_A_XRAA233_1","RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE [QUINONE]","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",5,"GLY A 157;GLY A 158;ASN A 160;GLU A  57;ILE A  58","None","1.36A","3owxA-4q38A:undetectable","3owxA-4q38A:21.25"],["4B3Q_A_NVPA999_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",4,"LEU A  45;VAL A 119;TYR A 113;LEU A 143","None","0.90A","4b3qA-4q38A:undetectable","4b3qA-4q38A:20.21"],["4EJJ_A_NCTA501_1","CYTOCHROME P450 2A6","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",4,"PHE A 224;GLY A 171;ILE A 131;PHE A 219","None","0.81A","4ejjA-4q38A:undetectable","4ejjA-4q38A:20.92"],["4FGL_D_CLQD303_1","RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE [QUINONE]","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",4,"GLY A 157;GLY A 158;GLU A  57;ILE A  58","None","0.89A","4fglD-4q38A:undetectable","4fglD-4q38A:21.31"],["4MFL_B_GCSB502_1","PUTATIVE UNCHARACTERIZED PROTEIN TCP24;TEICOPLANIN PSEUDOAGLYCONE","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",5,"GLN A 142;MET A 161;TRP A 163;TRP A 164;PHE A 281","TEC A 404 ( 4.0A);TEC A 404 (-4.3A);TEC A 404 (-4.6A);TEC A 404 (-3.7A);COA A 403 (-3.4A)","0.66A","4mflA-4q38A:51.3","4mflA-4q38A:97.68"],["4MFP_B_GCSB503_1","PUTATIVE UNCHARACTERIZED PROTEIN TCP24;TEICOPLANIN PSEUDOAGLYCONE","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",5,"GLN A 142;MET A 161;TRP A 163;TRP A 164;PHE A 281","TEC A 404 ( 4.0A);TEC A 404 (-4.3A);TEC A 404 (-4.6A);TEC A 404 (-3.7A);COA A 403 (-3.4A)","0.34A","4mfpA-4q38A:50.5","4mfpA-4q38A:97.68"],["4MFQ_B_GCSB503_1","PUTATIVE UNCHARACTERIZED PROTEIN TCP24;TEICOPLANIN PSEUDOAGLYCONE","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",5,"GLN A 142;MET A 161;TRP A 163;TRP A 164;PHE A 281","TEC A 404 ( 4.0A);TEC A 404 (-4.3A);TEC A 404 (-4.6A);TEC A 404 (-3.7A);COA A 403 (-3.4A)","0.73A","4mfqA-4q38A:50.8","4mfqA-4q38A:97.68"],["4O0W_A_ADNA501_1","AURORA KINASE A","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",5,"LEU A  10;GLY A  11;ALA A  70;THR A  16;LEU A  20","None","0.91A","4o0wA-4q38A:undetectable","4o0wA-4q38A:22.62"],["4Q36_A_GCSA404_1","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",5,"MET A 161;TRP A 163;TRP A 164;HIS A 196;PHE A 281","TEC A 404 (-4.3A);TEC A 404 (-4.6A);TEC A 404 (-3.7A);TEC A 404 (-4.1A);COA A 403 (-3.4A)","0.13A","4q36A-4q38A:50.9","4q36A-4q38A:100.00"],["4R82_A_ACTA205_0","OXIDOREDUCTASE","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",4,"GLY A  87;ARG A 129;GLU A 226;PHE A 224","None","1.22A","4r82A-4q38A:undetectable;4r82B-4q38A:undetectable","4r82A-4q38A:21.04;4r82B-4q38A:21.04"],["5IZJ_F_AZ1F2_1","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;47P-AZ1-DAR-DAR-DAR","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",5,"GLY A 234;SER A 235;GLY A 318;VAL A 320;LEU A 262","TEC A 404 ( 3.9A);None;None;None;None","1.28A","5izjB-4q38A:undetectable","5izjB-4q38A:20.27"],["5JW1_A_CELA602_1","PROSTAGLANDIN G\/H SYNTHASE 2","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",6,"VAL A 197;TYR A 209;LEU A 204;ALA A 216;GLY A 234;SER A 236","TEC A 404 ( 4.2A);None;COA A 403 (-4.6A);None;TEC A 404 ( 3.9A);COA A 403 (-3.1A)","1.22A","5jw1A-4q38A:undetectable","5jw1A-4q38A:21.44"],["6G2P_A_TRPA502_0","FLAVIN-DEPENDENT L-TRYPTOPHAN OXIDASE VIOA","4q38","PUTATIVE UNCHARACTERIZED PROTEIN TCP24","Actinoplanes teichomyceticus",4,"TYR A 113;LEU A 143;TYR A 109;VAL A  50","None","1.33A","6g2pA-4q38A:undetectable","6g2pA-4q38A:22.12"]]